光热转换材料及其在脱盐领域的应用

光热脱盐技术在缓解水资源短缺和减少水环境污染等方面具有重要的应用前景,已吸引了各国研究者的广泛关注。光热脱盐主要是利用光热转换材料将吸收的太阳光能直接、高效地转化为热能,以蒸发水分实现含盐水脱盐和水质净化,其效率取决于光热转换材料的性能。本文综述了近年来太阳能光热转换材料如金属基材料、碳基材料、半导体材料、有机聚合物材料、复合光热材料的研究现状及其光热转换机理,并介绍了光热转换材料在脱盐领域的应用进展。基于上述分析,对光热转换材料在未来脱盐领域的研究前景进行了展望,提出应针对光热转换材料的低强度全光谱吸收和高效转化利用、光热稳定性和重复使用性提高,以及光热脱盐系统的热传递损失最小化和热量利用最大化等方面进行深入探析。     

MXenes的制备及其光热性能在癌症治疗中的应用

近年来,过渡金属碳化物和氮化物(MXenes)作为一种新型二维材料以其独特的晶体特征和结构特性受到越来越多的关注,尤其是在能源、催化、生物医学等领域得到广泛应用。MXenes独特的晶体结构和表面特性赋予其优异的电子、光学、磁性等理化性能。此外,MXenes较大的比表面积和较高的光热转换效率,使其在生物医学领域尤其是肿瘤治疗方面得到大量应用。本文主要介绍了MXenes的合成方法和光热特性,重点总结分析了MXenes的光热性能在癌症治疗中的应用等研究进展,并提出了MXenes在癌症治疗中存在的潜在挑战和前景。     

特异性靶点光热剂在光热治疗领域的研究进展北大核心CSCD

光热疗法是一种利用光热剂将光能转变为热能,通过局部加热并触发生化过程来杀死肿瘤细胞的一种肿瘤治疗方法。由于照射光具有易聚焦和易调整的特性,因此光热治疗能以非侵入的方式,直接、精准地在局部进行治疗。本文对不同类型的光热剂的最新进展进行了总结,根据识别位点的不同,从“细胞外靶点”、“细胞上的靶点”和“细胞内靶点”三个方面,对典型的特异性靶点光热剂进行了详细的介绍。最后讨论了基于光热转换纳米材料的肿瘤光热治疗在临床应用方面面临的局限性和挑战。     

一种用于肿瘤治疗的高光热转换效率和高稳定性的光热剂

基于香豆素荧光团设计合成了一种光热剂(ECEI),其光热转换效率可达 85.78%。此外,冷热循环的实验结果表明,ECEI 具有良好的光稳定性。即使在线粒体膜电位受损的情况下,ECEI 也能有效靶向线粒体,在激光照射下诱导癌细胞死亡。这使 ECEI能够最大程度地破坏线粒体,从而抑制肿瘤细胞的繁殖。对小鼠肿瘤照射 1次后,小鼠肿瘤在 10 d内逐渐消失,这表明ECEI具有良好的肿瘤抑制效果。     

一种用于肿瘤治疗的高光热转换效率和高稳定性的光热剂

基于香豆素荧光团设计合成了一种光热剂(ECEI),其光热转换效率可达 85.78%。此外,冷热循环的实验结果表明,ECEI 具有良好的光稳定性。即使在线粒体膜电位受损的情况下,ECEI 也能有效靶向线粒体,在激光照射下诱导癌细胞死亡。这使 ECEI能够最大程度地破坏线粒体,从而抑制肿瘤细胞的繁殖。对小鼠肿瘤照射 1次后,小鼠肿瘤在 10 d内逐渐消失,这表明ECEI具有良好的肿瘤抑制效果。     

聚吡咯及其纳米复合材料在光热治疗领域的应用

光热治疗是近年来兴起的一种治疗方法,具有靶向性强、适应性广的特点。在光热治疗中,通过光热剂对光的吸收将光能转化为热能,从而实现治疗作用,因而光热剂的光热转化性能直接决定了光热治疗的效果。光热剂的种类丰富,涵盖由无机到有机等组成和性能各异的多种材料。其中,聚吡咯具备良好的生物相容性、优异的光稳定性以及光热转化性能,在光热治疗领域受到广泛关注,是一种拥有巨大应用潜力的光热剂,然而其在光热治疗领域的发展趋势及前景却鲜有报道。本文综述了聚吡咯及其纳米复合材料的制备方法,详述了聚吡咯及其纳米复合材料在光热治疗领域中的应用情况,包括聚吡咯基纳米材料的自身性能和实际光热治疗的效果,指出以聚吡咯为基体或修饰材料来制备具有CT、磁共振、光声显影及光热治疗性能的聚吡咯基复合材料已成为发展趋势。在此基础上,本文还总结了聚吡咯基纳米复合材料在制备和应用中存在的问题,并分析了其在发展过程中遇到的挑战以及在生物医学应用中的前景。     

有机纳米材料在肿瘤光热治疗中的应用

光热治疗是利用在近红外具有较强光吸收的材料将光能转化为热能从而杀死癌细胞,与传统的化疗、放疗相比具有副作用小、治疗特异性好的优点。近年来各种不同的纳米材料被用于肿瘤光热治疗,并在动物肿瘤模型实验中取得了令人鼓舞的治疗效果。本文重点介绍几种典型的有机纳米材料在光热治疗中的应用,并讨论这一新兴领域的发展趋势。     

小分子基温敏聚合物纳米粒子的制备及在近红外二区荧光成像与光热治疗中的应用

以有机小分子4,9-二(5-9H-芴-2-基-噻吩-2-基)-6',7-联苯[1,2,5]噻二唑并[3,4-g]喹喔啉(TQF)为前驱体, 通过化学方法将其修饰为可引发可逆加成-断裂链转移聚合(RAFT)反应的小分子链转移剂TQF-苯基硫代链 转移剂（CTA）. 以TQF-CTA为链转移剂, 以偶氮二异丁腈为引发剂, 引发N-异丙基丙烯酰胺(NIPAAm)和 甲基丙烯酸寡聚乙二醇酯(OEGMA)发生RAFT聚合反应, 合成了具有良好水溶性和较低临界溶解温度(LCST)的小分子基共聚物[TQF-P(NIPAAm-co-OEGMA), TPNO]. 将其直接溶于水中可制备成温敏的球形纳米粒子 TPNO NPs. 研究结果表明, TPNO NPs在温度大于LCST(35 ℃)时表现出一个明显的粒径变化和显著的荧光 增强行为(2.2倍), 并成功实现了对活体小鼠血管与肿瘤的明亮近红外二区(NIR-Ⅱ)荧光成像(FI). 同时, TPNO NPs有着良好的光热转换效率(PCE=29.8%), 通过体外细胞实验证明了其对细胞具有较好的光热治疗(PTT)效果.     

尖晶石锂锰氧结构中的氧缺陷及其修复方法

研究了氧缺陷型尖晶石锂锰氧化物的结构与电化学性能, 根据缺陷化学理论提出了弥补氧缺陷的办法. X射线衍射(XRD)结果表明, 在真空条件下于750 ℃焙烧不同时间后锂锰氧化物主要物相仍可保持尖晶石结构, 并伴随有少量Mn₃O₄和Li₂MnO₃杂相. 充放电测试及交流阻抗结果表明, 锂锰氧化物材料的放电容量随氧缺陷的增加而降低, 随着氧缺陷的增大, 表面膜阻抗及电荷传递阻抗增大、锂离子在锂锰氧固体中的嵌入与累积量减小使电化学性能恶化. 加入LiOH•H₂O和通入氧气焙烧可在一定程度上修复氧缺陷.     

水热法制备Cu-HMS催化剂及其催化草酸二甲酯加氢性能的研究

以十六胺为模板剂,采用水热合成法制备了一系列不同铜负载量的Cu-HMS催化剂,并考察了其对草酸二甲酯加氢制乙二醇反应的催化性能.同时,通过X射线粉末衍射(XRD)、N_2低温吸附脱附、红外光谱(FI-IR)、H_2程序升温还原(H_2-TPR)及透射电镜(TEM)等手段对催化剂进行了系统表征.结果表明,铜负载量对催化剂活性组分的分散性和载体之间的相互作用力影响很大.实验结果表明,以20%铜负载量制备的Cu-HMS催化剂催化性能优势明显.在反应温度为205℃、压力为2.0 MPa、氢酯比为80 mol/mol及液时空速为0.4 h-1的条件下,草酸二甲酯的转化率接近100%,乙二醇的选择性高达98.11%.     

Ag@TiO2 Nanoprisms with Highly Efficient Near‐Infrared Photothermal Conversion for Melanoma Therapy

Melanoma is a primary reason of death from skin cancer and associated with high lethality. Photothermal therapy (PTT) has been developed into a powerful cancer treatment technique in recent years. Here, we created a low‐cost and high‐performance PTT agent, Ag@TiO₂ NPs, which possesses a high photothermal conversion efficiency of ≈65 % and strong near‐infrared (NIR) absorption about 808 nm. Ag NPs were synthesized using a two‐step method and coated with TiO₂ to obtain Ag@TiO₂ NPs by a facile sol‐gel method. Because of the oxide, Ag@TiO₂ NPs exhibit remarkable high photothermal conversion efficiencies and biocompatibility in vivo and in vitro. Cytotoxicity and therapeutic efficiency of photothermal cytotoxicity of Ag@TiO₂ NPs were tested in B16‐F10 cells and C57BL/6J mice. Under light irradiation, the elevated temperature causes cell death in Ag NPs‐treated (100 μg mL^?1) cells in vitro (both p<0.01). In the case of subcutaneous melanoma tumor model, Ag@TiO₂ NPs (100 μg mL^?1) were injected into the tumor and irradiated with a 808 nm laser of 2 W cm^?2 for 1 minute. As a consequence, the tumor volume gradually decreased by NIR laser irradiation with only a single treatment. The results demonstrate that Ag@TiO₂ NPs are biocompatible and an attractive photothermal agent for cutaneous melanoma by local delivery.     

肿瘤靶向Pt-Cu基纳米平台用于近红外二区光声成像引导的光热治疗

基于层层（LBL）自组装技术,在Pt-Cu纳米合金表面依次包覆带正电的聚赖氨酸（PLL）和带负电的透明质酸（HA）,成功构筑Pt-Cu@PLL@HA纳米平台。HA不仅延长了纳米平台血液循环时间,还可实现肿瘤主动靶向作用,提升肿瘤部位富集效果。在肿瘤区域透明质酸酶（HAase）作用下HA快速降解,释放Pt-Cu@PLL （+）颗粒,有利于肿瘤细胞特异性摄取。基于Pt-Cu合金良好的近红外二区（NIR-Ⅱ）吸收性能,实现了NIR-Ⅱ光声成像引导的NIR-Ⅱ光热高效抗肿瘤效果。     

介孔钛纳米复合团簇应用于光热-光动力疗法

在本文,采用水热法合成了一种新型的介孔二氧化钛/碳/亚甲蓝复合纳米团簇(TiO₂@C-MB),并应用于肿瘤细胞的光动力(PDT)和光热治疗(PTT)。系统中介孔二氧化钛作为有效的光敏剂,MB作为重要的光敏添加剂以改善二氧化钛纳米晶的光化学效应,并将其光响应区域拓宽至光动力学疗法的理想治疗窗(650~900 nm)。柠檬酸在水热条件下被还原成碳并裹覆在二氧化钛表面。碳层表现出良好的光热效果,也充当多功能的电子受体以加速生成单线态氧。该纳米团簇不仅可以保持肿瘤细胞内部高浓度的MB和二氧化钛以产生大量的单线态氧杀死肿瘤细胞,而且可以避免MB退化失活。     

钼蓝分光光度法测定铅精矿中二氧化硅

采用钼蓝分光光度法测定铅精矿中二氧化硅的含量,研究了显色酸度、钼酸铵用量、加入钼酸铵后的稳定时间、还原液用量以及加入还原液后稳定时间等因素对测定的影响,确定了最佳测定条件。方法加标回收率在97.01%~103.8%,相对标准偏差(RSD)在1.3%~8.5%。方法操作简单,流程短,干扰少,具有较好的精密度和准确度,能够满足铅精矿中二氧化硅含量的测定。     

A Photoinduced Nonadiabatic Decay-Guided Molecular Motor Triggers Effective Photothermal Conversion for Cancer Therapy

It remains highly challenging to identify small molecule-based photothermal agents with a high photothermal conversion efficiency (PTCE). Herein, we adopt a double bond-based molecular motor concept to develop a new class of small photothermal agents to break the current design bottleneck. As the double-bond is twisted by strong twisted intramolecular charge transfer (TICT) upon irradiation, the excited agents can deactivate non-radiatively through the conical intersection (CI) of internal conversion, which is called photoinduced nonadiabatic decay. Such agents possess a high PTCE of 90.0 %, facilitating low-temperature photothermal therapy in the presence of a heat shock protein 70 inhibitor. In addition, the behavior and mechanism of NIR laser-triggered molecular motions for generating heat through the CI pathway have been further understood through theoretical and experimental evidence, providing a design principle for highly efficient photothermal and photoacoustic agents.     

Phase‐Transition Induced Conversion into a Photothermal Material: Quasi‐Metallic WO2.9 Nanorods for Solar Water Evaporation and Anticancer Photothermal Therapy

Phase transition from WO₃ to sub‐stoichiometric WO_2.9 by a facile method has varied the typical semiconductor to be quasi‐metallic with a narrowed band gap and a shifted Femi energy to the conduction band, while maintaining a high crystallinity. The resultant WO_2.9 nanorods possess a high total absorption capacity (ca. 90.6 %) over the whole solar spectrum as well as significant photothermal conversion capability, affording a conversion efficiency as high as around 86.9 % and a water evaporation efficiency of about 81 % upon solar light irradiation. Meanwhile, the promising potential of the nanorods for anticancer photothermal therapy have been also demonstrated, with a high photothermal conversion efficiency (ca. 44.9 %) upon single wavelength near‐infrared irradiation and a high tumor inhibition rate (ca. 98.5 %). This study may have opened up a feasible route to produce high‐performance photothermal materials from well‐developed oxides.     

介孔钛纳米复合团簇应用于光热-光动力疗法

采用水热法合成了一种新型的介孔二氧化钛/碳/亚甲蓝复合纳米团簇(TiO_2@C-MB),并应用于肿瘤细胞的光动力(PDT)和光热治疗(PTT)。系统中介孔二氧化钛作为有效的光敏剂,MB作为重要的光敏添加剂以改善二氧化钛纳米晶的光化学效应,并将其光响应区域拓宽至光动力学疗法的理想治疗窗(650~900 nm)。柠檬酸在水热条件下被还原成碳并裹覆在二氧化钛表面。碳层表现出良好的光热效果,也充当多功能的电子受体以加速生成单线态氧。该纳米团簇不仅可以保持肿瘤细胞内部高浓度的MB和二氧化钛以产生大量的单线态氧杀死肿瘤细胞,而且可以避免MB退化失活。     

A Photoinduced Nonadiabatic Decay‐Guided Molecular Motor Triggers Effective Photothermal Conversion for Cancer Therapy

It remains highly challenging to identify small molecule‐based photothermal agents with a high photothermal conversion efficiency (PTCE). Herein, we adopt a double bond‐based molecular motor concept to develop a new class of small photothermal agents to break the current design bottleneck. As the double‐bond is twisted by strong twisted intramolecular charge transfer (TICT) upon irradiation, the excited agents can deactivate non‐radiatively through the conical intersection (CI) of internal conversion, which is called photoinduced nonadiabatic decay. Such agents possess a high PTCE of 90.0 %, facilitating low‐temperature photothermal therapy in the presence of a heat shock protein 70 inhibitor. In addition, the behavior and mechanism of NIR laser‐triggered molecular motions for generating heat through the CI pathway have been further understood through theoretical and experimental evidence, providing a design principle for highly efficient photothermal and photoacoustic agents.     

Facile Fabrication of Near‐Infrared‐Responsive and Chitosan‐Functionalized Cu2Se Nanoparticles for Cancer Photothermal Therapy

Photothermal therapy has attracted much interest for use in cancer treatment in recent years. In this study, Cu₂Se nanoparticles as a novel photothermal agent modified by chitosan (CS‐Cu₂SeNPs) were successfully synthesized through a facile route at room temperature. The as‐synthesized CS‐Cu₂SeNPs exhibited good water solubility and significant stability. CS‐Cu₂SeNPs can efficiently convert near‐infrared (NIR) light into heat and exhibit excellent thermostability. In vitro experiments showed that CS‐Cu₂SeNPs had selective cellular uptake between cancer and normal cells and expressed clear anticancer activity on A375 and HeLa human cancer cells. In addition, the anticancer activity was increased to about 400 % by combination with a laser at 808 nm, which acted through induction of apoptosis with the involvement of intrinsic and extrinsic pathways. CS‐Cu₂SeNPs irradiated with a laser effectively triggered the intracellular reactive oxygen species (ROS) overproduction that promoted cell apoptosis. Therefore, the developed CS‐Cu₂SeNPs could be used as a novel phototherapeutic agent for the photothermal therapy of human cancers.